Biotechnology · Healthcare
Board Member
2026-10-23–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Bolt Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get BOLT alertsDr. Sheila Gujrathi is recorded as Board Member at Bolt Biotherapeutics, Inc. (BOLT) since October 23, 2026. Bolt Biotherapeutics, Inc. reported in an 8-K filed October 23, 2026 that Dr. Sheila Gujrathi was appointed Chief Strategy Officer, effective October 23, 2026. Bolt Biotherapeutics, Inc. reported in an 8-K filed October 23, 2026 that Dr. Sheila Gujrathi was appointed Class II director of the Board, effective October 23, 2026. Bolt Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Bolt Biotherapeutics, Inc. includes William P. Quinn (CEO, CFO and Board Member), Grant Yonehiro (COO), Sarah Nemec (Chief Accounting Officer) and 4 others.
“In accordance with the Merger Agreement, on October 23, 2026, effective immediately after the First Effective Time, Dr. Sheila Gujrathi was appointed as the Chief Strategy Officer of the Company.”
“In accordance with the Merger Agreement, on October 23, 2026, effective immediately after the First Effective Time, Dr. Sheila Gujrathi was appointed to the Board as a Class II director of the Board.”
2026-10-23–present
2026-10-23–present
Biotechnology · Healthcare
Board Member
2026-10-23–present